Loading the company…
Loading the company…
㈜덴탈맥스
English name as filed with DART, Korea’s corporate disclosure system · Correct the English name ›
Last updated 2026-10-11 · Korean page ›
Verification level — how far we have checked
L0 · Public records — NPS workforce · filed financials · patents — public data
A company based in Chungnam, founded in 2012. Industry: Medical & Precision Devices. Revenue for 2025 was ₩18.2bn. It has 46 employees enrolled in the National Pension Service (as of Aug 2026). It is externally audited; the latest audit opinion is “Unqualified”.
Loading…
Latest filing 2015-03-19 · latest registration 2016-09-02 · newest first
본 발명은 인공치아용 지르코니아 다층블록의 제조방법에 관한 것으로, 더욱 상세하게는 3mol%의 yttrium oxide-tetragonal zirconia polycrystal 및 유기바인더를 혼합하는 제1원료혼합단계, 3mol%의 yttrium oxide-tetragonal zirconia polycrystal, 5mol%의 yttrium oxide-tetragonal zirconia polycrystal 및 유기바인더를 혼합하는 제2원료혼합단계, 5mol%의 yttrium oxide-tetragonal zirconia polycrystal 및 유기바인더를 혼합하는 제3원료혼합단계, 상기 제1원료혼합단계, 제2원료혼합단계 및 상기 제3원료혼합단계를 통해 제조된 혼합물을 압축성형용 금형에 순차적으로 투입하고 압축성형하는 압축성형단계 및 상기 압축성형단계를 통해 압축성형된 성형체를 하소하는 하소단계로 이루어진다. 상기의 과정으로 이루어지는 인공치아용 지르코니아 다층블록의 제조방법은 제조과정에서 yttrium oxide의 함량을 조절하여 착색용액에 함침된 후에 자연치아와 유사한 색상을 나타내는 인공치아용 지르코니아 다층블록을 제공한다.
KIPO KIPRIS · checked 2026-10-15 · newest filings first · right: registration date (filing date if not yet registered) · 1 of 1 · titles and abstracts are in Korean as filed · click a row for details ▾
For now we hold public records only (National Pension Service · DART filings · patents · registers · press). When the company files material in our IR Room, it moves to L1. We do not score or rate companies — we only state how far we have checked.
| KRW bn | 2024 | 2025 |
|---|---|---|
| Revenue | 16.6 | 18.2 |
| Cost of sales | 9.1 | 10.0 |
| Gross profit (loss) | 7.5 | 8.3 |
| Selling, general and administrative expenses | 4.1 | 4.7 |
| Operating income (loss) | 3.4 | 3.6 |
| Non-operating income | 0.5 | 0.6 |
| Other gains | 0.0 | 0.1 |
| Finance income | 0.1 | 0.0 |
| Other | 0.4 | 0.6 |
| Non-operating expenses | 0.2 | 0.5 |
| Other losses | 0.0 | 0.1 |
| Finance costs | 0.1 | 0.1 |
| Other | 0.2 | 0.4 |
| Net income (loss) | 3.0 | 3.3 |
Revenue ₩18.2bn, up 10.0% YoY.
Operating margin 19.6% (prior 20.6%).
Net income ₩3.3bn.
Need more than is shown here? Ask for more information — full review report · valuation · executive teaser · IM · competitor analysis · due diligence. Tell us what you need and we will reply by email with scope, cost and timing.
Is this your company?
If anything here is wrong, tell us — we check it against the original and correct it. You do not need to join. If you would like your financials verified and this page completed, that is a separate process.
Headlines and links to public articles only · not checked by us (original ↗) · articles are in Korean — English headlines are our translation; where none is shown, “Read in English ›” opens a machine translation · “Broker view” is a forecast, not reported results · checked 2026-11-06